Friday, July 10, 2026

pharma · Neurogenic Orthostatic Hypotension

HAC Pharma

HAC Pharma clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Caen, FR HQ
2007 Founded
51 Employees
EMA registrant Type
Company details
Status
Public
HQ
Caen, FR
Founded
2007
Employees
51
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Programs

HAC Pharma projects

1 ClinicalTrials.gov programs sponsored by HAC Pharma.

HAC Pharma has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. HAC2018-001

    H.A.C. Pharma

    Neurogenic Orthostatic Hypotension

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does HAC Pharma have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.